CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...